Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
56.9M
-
Shares change
-
-1.25M
-
Total reported value, excl. options
-
$1.26B
-
Value change
-
-$31.6M
-
Put/Call ratio
-
1.37
-
Number of buys
-
68
-
Number of sells
-
-60
-
Price
-
$22.17
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q2 2022
171 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2022.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.9M shares
of 58.6M outstanding shares and own 96.95% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.2M shares), WELLINGTON MANAGEMENT GROUP LLP (5.15M shares), BlackRock Inc. (4.84M shares), Bellevue Group AG (4.06M shares), STATE STREET CORP (3.4M shares), FMR LLC (2.94M shares), Rock Springs Capital Management LP (2.93M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.55M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.32M shares), and FIRST TRUST ADVISORS LP (1.73M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.